Varenzin-CA1 for Cats | Treatment for Anemia Associated With Chronic Kidney Disease | Orally Administered Liquid | 25 mg/mL

Hero Image	https://images.salsify.com/image/upload/s--7HVskixD--/gsxvxvzetmsdwi8juouq.jpg
Back Image	https://images.salsify.com/image/upload/s--OvH5ZzjY--/obzzcasmfvgguvo2d0es.jpg
Indications	INDICATIONS: Varenzin-CA1 is indicated for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats.
Important Safety Information	IMPORTANT SAFETY INFORMATION: For oral use in cats only. Keep this drug, including used syringes, out of reach of children. Wash hands immediately after use. In case of accidental ingestion, seek medical advice immediately. Women who are pregnant or may become pregnant should administer the product with caution. Varenzin-CA1 should not be administered to cats that are pregnant, lactating or intended for breeding or to cats with known hypersensitivity to molidustat. Use with caution in cats with a history of seizures and in cats predisposed to thromboembolic disease. Hematocrit (HCT) or packed cell volume (PCV) levels should be monitored regularly as polycythemia may result from use of Varenzin-CA1. Varenzin-CA1 has not been evaluated in cats less than 1 year of age. The most common adverse reactions included vomiting, increases in systolic blood pressure and mild transient increase in serum potassium.
Product Label URL	https://www.elancolabels.com/us/varenzin